for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Gene Techno Science Co Ltd (Parent)

4584.T

Latest Trade

967.00JPY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

568.00

 - 

1,075.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Gene Techno Science signs collaborative research agreement with chromocenter

July 30 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it signed collaborative research agreement with chromocenter Inc..Says two entities mainly cooperate on establishment of cell lines construction related the basic technologies .

Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology

Nov 9 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it commenced the phase III clinical trial for biosimilars in ophthalmology, which is a joint work between the co and Senju Pharmaceutical Co Ltd .

Gene Techno Science raises 301.9 mln yen via private placement

Gene Techno Science Co Ltd <4584.T>:Says it raised 301.9 million yen via private placement.

Gene Techno Science announces change of chairman and president

Gene Techno Science Co Ltd <4584.T> :Says it appoints current president Masanari Kawaminami as new chairman, Masaharu Tani as new president, effective on April 1.

Gene Techno Science signs joint research and development contract with Juntendo University

Gene Techno Science Co Ltd <4584.T>: Says it signed a joint research and development contract for new immunosuppressive therapy with Juntendo University on Feb. 27 .Says contract period is from March 1, 2017 to Feb. 29, 2020.

Gene Techno Science says business and capital alliance with JSR

Gene Techno Science Co Ltd <4584.T>: says business and capital alliance with Japan-based firm JSR . Says two entities will cooperate manufacturing process development and manufacture of biosimilars and bio-drugs related pipeline, as well as manufacture of commercial biopharmaceuticals, etc .Says it to issue 343,407 shares (3.67 percent stake) to JSR on Dec. 22 via private placement for 500,000,592 yen.

Gene Techno Science commences phase III clinical trial for renal anemia treatment drug

Gene Techno Science Co Ltd <4584.T>: Says it commenced the phase III clinical trial for a renal anemia treatment drug in Japan .Says the drug is jointly developing by the co and SANWA KAGAKU KENKYUSHO.

Gene Techno Science to sign memorandum of agreement with Dydo Drinco Inc

Gene Techno Science Co Ltd <4584.T>:Says it will sign memorandum of agreement with Dydo Drinco Inc <2590.T> to co-develop healthcare business on July 1.

GK Launchpad12 to be Gene Techno Science's parent company since June 6

Gene Techno Science Co Ltd <4584.T>: Says GK Launchpad12 will be Gene Techno Science's parent company as the result of the takeover bid, effective June 6 . Says GK Launchpad12 will increase stake in the company to 58.2 percent, up from 18.1 percent .Says Whiz Partners Inc will cut stake in the company to 0 percent, down from 21.5 percent.

Gene Techno Science signs joint project contract with Senju Pharmaceutical

Gene Techno Science <4584.T>:Says it signed a joint project contract on follow-on biologics for treatment of ophthalmology with Senju Pharmaceutical on May 12.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up